Yoseph Atilaw

889 total citations
25 papers, 450 citations indexed

About

Yoseph Atilaw is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yoseph Atilaw has authored 25 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Yoseph Atilaw's work include Bioactive natural compounds (6 papers), Natural product bioactivities and synthesis (6 papers) and Protein Degradation and Inhibitors (4 papers). Yoseph Atilaw is often cited by papers focused on Bioactive natural compounds (6 papers), Natural product bioactivities and synthesis (6 papers) and Protein Degradation and Inhibitors (4 papers). Yoseph Atilaw collaborates with scholars based in Sweden, Germany and Kenya. Yoseph Atilaw's co-authors include Máté Erdélyi, Jan Kihlberg, Vasanthanathan Poongavanam, Daniel Meibom, Anja Giese, Duy Nguyen, Lutz Lehmann, Lianne H. E. Wieske, Stephan Siegel and Giuseppe Ermondi and has published in prestigious journals such as Journal of Medicinal Chemistry, Chemistry - A European Journal and Molecules.

In The Last Decade

Yoseph Atilaw

25 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoseph Atilaw Sweden 11 358 132 63 61 57 25 450
Hongmin Liu China 9 227 0.6× 47 0.4× 55 0.9× 11 0.2× 47 0.8× 31 389
Sean M. Lynn United Kingdom 13 228 0.6× 34 0.3× 121 1.9× 22 0.4× 15 0.3× 28 450
Rashed N. Herqash Saudi Arabia 10 120 0.3× 49 0.4× 56 0.9× 15 0.2× 17 0.3× 47 304
Safiye Emirdağ Türkiye 11 197 0.6× 74 0.6× 164 2.6× 12 0.2× 19 0.3× 20 369
Laurence Philippe United States 9 264 0.7× 73 0.6× 143 2.3× 141 2.3× 12 0.2× 11 431
Kavitha Bharatham South Korea 11 297 0.8× 30 0.2× 64 1.0× 74 1.2× 5 0.1× 20 405
Xianchao Pan China 13 164 0.5× 65 0.5× 127 2.0× 68 1.1× 4 0.1× 39 402
Samima Khatun India 12 240 0.7× 125 0.9× 131 2.1× 36 0.6× 3 0.1× 30 355
Ayoung Baek South Korea 15 330 0.9× 58 0.4× 123 2.0× 173 2.8× 7 0.1× 28 601
Lydia Siragusa Italy 13 284 0.8× 72 0.5× 77 1.2× 169 2.8× 21 0.4× 22 451

Countries citing papers authored by Yoseph Atilaw

Since Specialization
Citations

This map shows the geographic impact of Yoseph Atilaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoseph Atilaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoseph Atilaw more than expected).

Fields of papers citing papers by Yoseph Atilaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoseph Atilaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoseph Atilaw. The network helps show where Yoseph Atilaw may publish in the future.

Co-authorship network of co-authors of Yoseph Atilaw

This figure shows the co-authorship network connecting the top 25 collaborators of Yoseph Atilaw. A scholar is included among the top collaborators of Yoseph Atilaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoseph Atilaw. Yoseph Atilaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wieske, Lianne H. E., Vasanthanathan Poongavanam, Yoseph Atilaw, et al.. (2024). Impact of Linker Composition on VHL PROTAC Cell Permeability. Journal of Medicinal Chemistry. 68(1). 638–657. 12 indexed citations
2.
Poongavanam, Vasanthanathan, Diego García Jiménez, Yoseph Atilaw, et al.. (2024). Exploring the chemical space of orally bioavailable PROTACs. Drug Discovery Today. 29(4). 103917–103917. 28 indexed citations
3.
Wieske, Lianne H. E., Yoseph Atilaw, Albert Ndakala, et al.. (2024). Antiviral Rotenoids and Isoflavones Isolated fromMillettiaoblatassp.teitensis. Journal of Natural Products. 87(4). 1003–1012. 5 indexed citations
4.
Atilaw, Yoseph, et al.. (2023). Macrocyclic Pyrrolizidine Alkaloids and Silphiperfolanol Angelate Esters from Solanecio mannii. European Journal of Organic Chemistry. 26(8). 2 indexed citations
5.
Wieske, Lianne H. E., Yoseph Atilaw, Vasanthanathan Poongavanam, Máté Erdélyi, & Jan Kihlberg. (2022). Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds. Chemistry - A European Journal. 29(8). e202202798–e202202798. 19 indexed citations
6.
Wieske, Lianne H. E., et al.. (2022). Going viral: an investigation into the chameleonic behaviour of antiviral compounds. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations
7.
Atilaw, Yoseph, et al.. (2022). Macrocyclic Pyrrolizidine Alkaloids and Silphiperfolanol Angelate Esters from Solanecio mannii. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations
8.
Atilaw, Yoseph, et al.. (2021). Antiviral iridoid glycosides from Clerodendrum myricoides. Fitoterapia. 155. 105055–105055. 7 indexed citations
9.
10.
Atilaw, Yoseph, et al.. (2021). Antibacterial and cytotoxic biflavonoids from the root bark of Ochna kirkii. Fitoterapia. 151. 104857–104857. 4 indexed citations
11.
Atilaw, Yoseph, Arvind Kumar Gupta, Andreas Orthaber, et al.. (2021). Antibacterial and cytotoxic prenylated dihydrochalcones from Eriosema montanum. Fitoterapia. 149. 104809–104809. 6 indexed citations
12.
Atilaw, Yoseph, et al.. (2021). Biflavanones, Chalconoids, and Flavonoid Analogues from the Stem Bark of Ochna holstii. Journal of Natural Products. 84(2). 364–372. 6 indexed citations
13.
Atilaw, Yoseph, Sandra Duffy, Arto Valkonen, et al.. (2020). Prenylated Flavonoids from the Roots of Tephrosia rhodesica. Journal of Natural Products. 83(8). 2390–2398. 10 indexed citations
14.
Atilaw, Yoseph, Vasanthanathan Poongavanam, Duy Nguyen, et al.. (2020). Solution Conformations Shed Light on PROTAC Cell Permeability. ACS Medicinal Chemistry Letters. 12(1). 107–114. 117 indexed citations
15.
Poongavanam, Vasanthanathan, Yoseph Atilaw, Lianne H. E. Wieske, et al.. (2020). Predicting the Permeability of Macrocycles from Conformational Sampling – Limitations of Molecular Flexibility. Journal of Pharmaceutical Sciences. 110(1). 301–313. 40 indexed citations
16.
Peng, Cheng, Yoseph Atilaw, Jinan Wang, et al.. (2019). Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study. ACS Omega. 4(26). 22245–22250. 17 indexed citations
17.
Atilaw, Yoseph, Albert Ndakala, Hoseah M. Akala, et al.. (2017). Four Prenylflavone Derivatives with Antiplasmodial Activities from the Stem of Tephrosia purpurea subsp. leptostachya. Molecules. 22(9). 1514–1514. 10 indexed citations
18.
Muthaura, C.N., Joseph M. Keriko, Charles Mutai, et al.. (2017). Antiplasmodial, Cytotoxicity and Phytochemical Constituents of Four Maytenus Species Used in Traditional Medicine in Kenya. The Natural Products Journal. 7(2). 144–152. 1 indexed citations
19.
Atilaw, Yoseph, Sandra Duffy, Matthias Heydenreich, et al.. (2017). Three Chalconoids and a Pterocarpene from the Roots of Tephrosia aequilata. Molecules. 22(2). 318–318. 13 indexed citations
20.
Dagne, Ermias, et al.. (2011). Determination of Levels of Cathine in Catha edulis (Khat) Leaves and its Detection in Urine of Khat Chewers: A preliminary Report. 2(1). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026